ADMA Biologics nets $77.3mm via FOPO

14:40 EST 13 Feb 2020 | Elsevier Business Intelligence

ADMA Biologics Inc. (developing plasma-derived biologics for immune deficiencies and infectious diseases) netted $77.3mm via ...

Original Article: ADMA Biologics nets $77.3mm via FOPO


More From BioPortfolio on "ADMA Biologics nets $77.3mm via FOPO"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...